Molecular Imaging/ Nuclear Medicine


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Molecular Imaging/ Nuclear Medicine

  1. 1. SUBSPECIALTY CONTENT BROCHURE Radiological Society of North America 92nd Scientific Assembly and Annual Meeting November 26 – December 1, 2006 McCormick Place, Chicago Molecular Imaging/ Nuclear Medicine
  2. 2. Subspecialty content brochures organize the components of the annual meeting by subjects that correspond to radiologic subspecialties. We hope this brochure, along with the meeting program, helps to enrich and ease your experience at RSNA 2006. RSNA Annual Meeting CME Information RSNA® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. RSNA designates this educational activity for a maximum of 85 AMA PRA Category 1 Credits™ . Physicians should only claim credit commensurate with the extent of their participation in the activity. Saturday, November 25, 2006 12:00-2:00 Plenary Session AAPM/RSNA Physics Tutorial for Residents: Physics of Dual-Modality Imaging (E351) Sunday, November 26, 2006 10:45-12:15 Scientific Paper Sessions ISP: Nuclear Medicine (Featured Research: New Technologies and Tracers) (S502AB) 2:00-3:30 Refresher Courses Molecular Biology for Radiologists (Course RC117) (E353B) Musculoskeletal Imaging in Nuclear Medicine: Current and Emerging Methods (Course RC111) (N230) Therapeutic Response Assessment in Oncology (Course RC118) (N227) Monday, November 27, 2006 8:30-10:00 Refresher Courses Imaging Musculoskeletal Infections: How to Rationally Integrate Nuclear Medicine Imaging with MR Imaging and CT (Course RC211) (N227) New Thoracic Imaging Technologies: 64-Slice Multidetector CT, Postprocessing, PET/CT, and Enhanced Radiography Methods (Course RC201) (S406A)
  3. 3. PET/CT in Oncology I (Course RC218) (E450B) Target Identification and Bioinformatics (Course RC217) (E353A) 10:30-12:00 Scientific Paper Sessions Cardiac (Multimodality) (E353C) Molecular Imaging (Applications I) (E353A) Neuroradiology/Head and Neck (Head and Neck: Thyroid, Parathyroid) (N228) Nuclear Medicine (PET/CT in the Evaluation of Gastrointestinal Malignancies) (S502AB) Ultrasound (Science to Practice) (E451A) 1:30-3:00 Multisession Course Associated Sciences: Fusion Imaging: Technical and Clinical Highlights (N230) 3:00-4:00 Scientific Paper Sessions Breast Imaging (Multiple Modalities) (E253CD) Molecular Imaging (Technique Development) (E353A) Nuclear Medicine (PET/CT and Lymphoma) (S502AB) Tuesday, November 28, 2006 8:30-10:00 Refresher Courses Improving Your PET and PET/CT Clinical Practice: Lessons Learned with Emphasis on Case Studies, Image Pathologic Correlation, and Practical Issues with PET/CT (An Interactive Session) (Course RC311) (S405AB) Lymph Node Assessment in Oncologic Patients (An Interactive Session) (Course RC318) (S504ABC) Probe Design II (Course RC317) (E353A) 10:30-12:00 Scientific Paper Session Nuclear Medicine (Cardiovascular) (S502AB) 3:00-4:00 Scientific Paper Sessions ISP: Chest (Positron Emission Tomography) (E351) Molecular Imaging (Lymph Nodes) (E353A) Nuclear Medicine (PET/CT in Head and Neck, Neuroendocrine Tumors) (S502AB)
  4. 4. 4:30-6:00 Refresher Courses Categorical Course in Diagnostic Radiology: Genitourinary—Imaging in Gynecologic Malignancies (Course RC407) (E353C) Imaging Modalities and Instrumentation (Course RC417) (S504D) PET and PET/CT Imaging of the Extracranial Head and Neck (Course RC411) (S406B) Wednesday, November 29, 2006 8:30-6:00 Multisession Course RSNA-NCI Interventional Oncology Series (S501AB) 8:30-10:00 Refresher Courses Molecular-Genetic Imaging (Course RC517) (N228) PET/CT in Oncology II (Course RC518) (S406B) Role of Lung Scanning and CT Angiography in the Diagnosis of Pulmonary Embolism in the PIOPED II Era (Course RC511) (S401CD) 10:30-12:00 Scientific Paper Sessions Gastrointestinal (Gastrointestinal Oncology CT/PET) (E450B) ISP: Physics (Ultrasound, Nuclear Medicine, Optical Imaging) (S404AB) ISP: Genitourinary (Prostate Imaging) (E353B) Molecular Imaging (Imaging Agents) (E353A) Nuclear Medicine (Gastrointestinal and Genitourinary Malignancies) (S502AB) 3:00-4:00 Scientific Paper Sessions Breast Imaging (Multiple Modalities) (E253CD) Molecular Imaging (Applications II) (E352) Nuclear Medicine (Endocrine) (S502AB) Pediatric (Genitourinary and Nuclear Medicine) (N229) 4:15-5:00 Informatics IHE Nuclear Medicine: Whats New in 2006? (Informatics Classroom – Lakeside Learning Center) 4:30-6:00 Special Focus Session Multimodality Imaging: Fused Hardware or Software Fusion? (E353B)
  5. 5. Thursday, November 30, 2006 8:30-6:00 Multisession Course RSNA-NCI Interventional Oncology Series (S501AB) 8:30-10:00 Refresher Courses Advanced Single Photon Imaging of the Abdomen and Kidneys (Course RC611) (S504D) Clinical Translation (Course RC617) (S401AB) Minicourse: Image Optimization for Radiation Therapy Treatment Planning: CT, MR, and PET Review (Course RC622) (S404AB) Minicourse: Innovations and Advances in Medical Imaging Technology—Innovations and Advances in Radionuclide Imaging Technology (Course RC623) (S404CD) 10:30-12:00 Scientific Paper Sessions ISP: Molecular Imaging (Cell Tracking) (E253CD) Musculoskeletal (Bone and Soft-Tissue Tumors (S406B) Nuclear Medicine (Brain and Central Nervous System) (S502AB) 3:00-4:00 Special Focus Session Cancer Detection: Evaluation of Whole-Body MR Imaging versus CT and PET/CT (S404AB) 4:30-6:00 Refresher Courses Advances in Cardiac Nuclear Imaging: SPECT, SPECT/CT, and PET/CT (Course RC711) (N227) Head and Neck: Pitfalls and Imaging Applications (Course RC706) (E450A) Opportunities from Industry and Government (Course RC717) (S504D) Friday, December 1, 2006 8:30-10:00 Refresher Courses In Vivo Cellular Imaging (Course RC817) (E352) Integrating Cancer Genomics and Radiological Imaging: Practical Answers to Complex Problems (How-to Workshop) (Course RC831) (S504D) Practical PET/CT of the Chest, Abdomen, and Pelvis (Course RC811) (S406B)
  6. 6. Education Exhibits Space No. Exhibit Title LL-BR5223-L MRI Screen Detected Breast Cancers in the BRCA Population: Ultrasound, Mammographic and Histopathologic Correlation LL-ED3411 Nuclear Medicine Case of the Day LL-MI4952 Radiogenomics: A New Field of Radiological Research LL-MI4953 Detection of Lymph Node Metastasis: Finding a Trojan Horse LL-MI4954 Imaging Angiogenesis: An Evidence-based Review—Are Current Imaging Techniques Good Enough? LL-MI4955 Paramagnetic Labeling of Cells for Visualization by MR Imaging: Important Issues to Consider LL-MI5401 Review of Liposome Nanoparticles as Contrast and Targeted Therapeutic Agents LL-MI5402-L Molecular Imaging and Contrast Agent Database (MICAD): A Freely Accessible Online Source of Scientific Information LL-MI5403 Out of Breath and Out of Control: An Update on the Central Role of Hypoxia in Oncogenesis and Implications on Diagnosis and Management LL-MI5404-R Nanotechnology Development and Utilization for Imaging and Image-guided Cancer Therapies: A Primer for Diagnostic and Interventional Radiologists LL-NM2609 Spatial Distribution of Sentinel Lymph Nodes Displayed with 3-D Volume-rendering Multimodal Fused Images in Head and Neck Cutaneous Malignant Tumor LL-NM2610-L11 Lymphoscintigraphy: Reviewing the Unexpected LL-NM2611 FDG-PET And FDG-PET MR Imaging Co- Registration in Brain Tumor Recurrence versus Radiation Changes LL-NM2612 Head and Neck Cancer: The Role of 18- fluorodeoxyglucose Positron Emission Tomography (FDG PET) CT in Identification of Unknown Primary Tumours and in Subsequent Patient Management.
  7. 7. LL-NM2613 PET/CT of Neck Musculature: Normal Anatomy, Variants, and Post-treatment Findings LL-NM2614 Do Oral and Intravenous Contrast Have a Role in PET-CT Studies of the Abdomen and Pelvis? LL-NM2615 PET First: Malignant Lymphoma LL-NM2616 Use of PET Scanning in Post-transplant Lympho-Proliferative Disorder (PTLD) in Renal Transplant Patients LL-NM2617 The Use and Limitations of 18- fluorodeoxyglucose Positron Emission Tomography (FDG PET) CT Imaging of Lymphoma LL-NM2618 Castleman’s Disease: Role of FDG-PET and FDG-PET CT Imaging LL-NM2619 FDG-PET/CT (Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography) for Planning of Radiation Therapy LL-NM2620 Imaging of Gynecologic Malignancies with FDG PET–CT: Case Examples—Physiologic Activity and Pitfalls LL-NM2621 Role of Enhanced CT in Hybrid PET/CT for the Detection of non FDG-Avid Abdominal Malignant Tumors and Characterization of Inflammatory or Physiologic FDG Hyperactivity LL-NM2622 The Value of PET/CT in Bony Metastatic Disease LL-NM2623 18-Fluorodeoxyglucose Positron Emission Tomography (FDG PET) CT Imaging in the Assessment of a Range of Sarcomas: The Uses and Pitfalls LL-NM2624 Clinical Value of FDG PET in Patients with Connective Tissue Disease LL-NM2625-B11 Radionuclide Imaging of Skeletal and Soft Tissue Infection and Inflammation: The Right Agent for the Right Indication LL-NM2626-D11 Static Radionuclide Scintigraphy in the Evaluation of Renal Parenchymal Abnormalities in Children: Patterns, Pearls, and Pitfalls LL-NM2627-H11 Treatment of Thyroid Cancer with Radioactive Iodine, Emerging New Concepts, Controversies, and Changes in Clinical Practice
  8. 8. LL-NM3140 Web-based Tutorial on Clinical PET/CT and Reimbursement with Self Assessment Module LL-NM3141 FDG PET/CT in Thoracic Esophageal and Esophago-Gastric (EG) Junction Carcinoma: A Pictorial Review of Current Status LL-NM3142 Cutaneous Imaging on FDG-PET: Benign and Malignant LL-NM3143 Imaging Features of Sarcoidosis on FDG-PET LL-NM3144-H SPECT/CT Imaging: Clinical Utility of an Emerging Technology LL-NM3145 Dual-phase, Tc-99m Sestamibi SPECT-CT Imaging of the Parathyroid Glands in Patients with Primary Hyperparathyroidism LL-NM3146 Functional Anatomic Image Fusion for Somatostatin Receptor Positive Neuroendocrine Tumours LL-NM3147 SPECT/CT Fusion in the Evaluation of Parathyroid Adenomas LL-NM3148 SPECT Scans in the Assessment of Facet Joint Disease LL-NM3149 Usefulness of Intravenous Contrast Materials in 18F-FDG PET/CT Imaging and Potential Artifacts Leading to Misinterpretation: Modern PET/CT Technique and Its Interpretation LL-NM3150 Utilization of Oral Negative Contrast Agent in PET-CT Imaging LL-NM3151 Pictorial Review: PET/CT in the Planning and Assessment of Treatment Response of Radiofrequency Ablation Performed by CT Guidance LL-NM3152-L Imaging of Dementia with F-18 FDG PET: What You Should Remember LL-NM3153 Computer-aided Diagnosis and FDG-PET in Mild Cognitive Impairment and Alzheimers Disease LL-NM3154-D Patterns of Normal FDG Avidity in the Head and Neck on PET/CT LL-NM3155 Patterns of Benign Muscle Uptake Identified at F-18 fluorodeoxyglucose (FDG) PET/CT LL-NR5113 Patterns of Transspatial Involvement in Head and Neck Neoplastic Disease
  9. 9. Scientific Posters Space No. Poster Title LL-MI4384-B01 In Vivo Visualization of Neural Stem Cell Grafts by MicroPET Imaging LL-MI4385-B02 Dual Transfer of Gene and MR Contrast Agent into Stem Cells: Toward to Molecular MR Imaging of Stem Cell-mediated Gene Therapy LL-MI4386-B03 In Vivo MR Imaging of Magnetically Labeled Mesenchymal Stem Cells Transplanted Intravascularly for Cellular Therapy of Acute Renal Failure LL-MI4387-B04 Long-term MR Signal Characteristics of Ferucarbotran-labeled Human Mesenchymal Stem Cells in Vitro and in Vivo in Arthritic Joints LL-MI4388-B05 MR-Visible and Radiopaque Alginate Microcapsules for Immunoprotection of Cellular Therapeutics LL-MI4389-B06 Fast and Dynamic Scanning of Small Animals with High-Resolution Dual-source Micro-CT LL-MI4390-B07 Equivalent Cross-Relaxation Rate Imaging of Axillary Lymph Node LL-MI4391-B08 Mosaicing of Confocal Microscopic in Vivo Soft Tissue Video Sequences Improves Multimodality Approach LL-MI4392-D01 H1 MR Spectroscopic (MRS) Analysis of Intervertebral Disc Degeneration: Preliminary Study with Fresh Human Cadavers LL-MI4393-D02 Novel PARACEST MRI Agent for pH Measurement LL-MI4394-D03 A “Smart” PARACEST Agent for Detection of Caspase-3 Activity LL-MI4395-D04 Tumor Imaging with Cell Penetrating Peptides Activated by Matrix Metalloproteinases LL-MI4397-D06 Experimental Studies on Imaging of MMP2 Positive Tumor Cell by Gadolinium Labeled Activatable Cell-penetrating Peptides LL-MI4398-D07 Prostate Cancer Imaging Using Copper-64 and Technetium-99m Bombesin Analogs LL-MI4399-D08 Early Experience with Quantitative Autoradiography of Radiolabeled Choline in Mouse Xenografts of Human Prostate Cancer
  10. 10. LL-MI4400-H01 Magnetic Resonance Microscopy of Native Pancreatic Islets in ex Vivo Tissue Samples Allows Rough Islet Quantitation and Evaluation of Targeted Contrast Agents LL-MI4401-H02 Semi-automated Segmentation of Lymph Nodes following the Administration of Lymphotropic Nanoparticles: Comparison of Different Methodologies LL-MI4402-H03 Investigating in Vivo Molecular Specificity by Competitive Inhibition of Gadolinium- Immunomicelles-mediated MRI Enhancement of Atherosclerosis LL-MI4403-H04 Ultrasonographic Met-HGF/SF Functional Molecular Imaging of Tumor Margines and Targeted Therapy LL-MI4404-H05 Near Infrared Optical Imaging of Colonic Adenocarcinomas In the Presence of Ulcerative Colitis LL-MI4405-H06 A Study on the Trazodone in the Treatment of the Psychogenic Erectile Dysfunction Using fMRI LL-MI4406-L01 Multi-modality, Small Animal Imaging of Integrin Expression LL-MI4407-L02 Colloidal Gold Nanoparticles as a Blood Pool Contrast Agent for Computed Tomography in Mice LL-MI4408-L03 Comparison of the Body Diffusion-weighted MR Imaging and 18FDG-PET LL-MI4409-L04 MRI Measures of Angiogenesis Using Magnetic Iron Oxide Nanoparticles (MNP) Provides Noninvasive Assessment of Physiologic Changes Accompanied with Anti- hedgehog Therapy in Pancreatic Ductal Adenocarcinoma (PDAC) Xenograft Model LL-MI4410-L05 In Vitro and in Vivo Assessment of a Novel Folate-Receptor Targeted Contrast Agent (P866) for Tumor-specific MR Imaging in Breast and Ovarian Tumor Models LL-MI4411-L06 Oncology Molecular Imaging of GRP+ Receptor Expressing Breast Tumors with Siemens Micro-SPECT/CT Technology LL-MI4412-L07 Correlative Study between MSCT Perfusion Imaging and VEGF, CD34, and HIF-1a in Pancreatic Carcinoma LL-MI4413-R01 Visual Stimulation in Tract-tracing of Optic Pathway Using Maganase-enhanced MRI (MEMRI)
  11. 11. LL-MI4414-R02 Biological Validation of Functional Diffusion Mapping (fDM) in an Orthotopic Rodent Brain Tumor Model LL-MI4415-R03 P-31 MRS Measures the Metabolic Changes Caused by HIV-1 Infection in Human Lymphocytes and Thymocytes. LL-MI4416-R04 Variation in the Size of Lymph Nodes on Pre and Postcontrast Nanoparticle-enhanced MRI LL-MI4417-H07 Zebrafish Larvae as a Model System to Test Phagocytic Potential of Novel Nanoparticles LL-NM2066-B01 Towards Respiratory Gating and Correction of Clinical Myocardial Perfusion SPECT Scans LL-NM2067-B02 Effects of the Reverse Redistribution Phenomenon on 99m-sestamibi for Microcirculatory Disorder in Patients with AV Block LL-NM2068-B03 Myocardial Glucose Uptake on Whole-body 18F-FDG PET/CT in Patients with Suspected Malignancy: Correlation with Right Ventricle Function and/or Pulmonary Vascular Resistance LL-NM2069-B04 Clinical Significance of Focal Increased 18F–FDG Uptake in the Basal Myocardium after Radiotherapy for Esophageal Cancer LL-NM2070-B05 Comparison of FDG PET and Thallium-201 Scintigraphy in Diagnosis of Bone and Soft- tissue Tumors LL-NM2071-B06 Lymph Node Activity on Combined Indium- 111-Labeled Leukocyte and Technetium-99m- Sulfur Colloid Marrow Imaging of Failed Hip Prostheses: A Potential Pitfall in Image Interpretation LL-NM2072-B07 Correlation between Different Types of Superscan on Tc-99 MDP Bone Scan and Underlying Disease LL-NM2073-B08 Clinical Relevance of Discordant FDG-PET Findings of Bone Metastases with Bone Scan or CT LL-NM2074-B09 Comparison of Standard Dose versus Low Dose Attenuation Correction CT on Image Quality and PET Attenuation Correction LL-NM2075-B10 The Correlation between Increased Tumor Marker of CEA/ CA153 Serum Level and FDG PET/CT Finding for Breast Cancer Patients in Follow-up
  12. 12. LL-NM2076-D01 Targeted Imaging of ER-Positive Disease Using 99mTc-Labeled Estradiol LL-NM2077-D02 Incidence and Significance of Gallbladder Visualization on Post-therapy I-131 Scintigraphy LL-NM2078-D03 Scintigraphic Characteristics of Retroesophageal Parathyroid Lesions LL-NM2079-D04 The Meaning of Increased FDG Uptake in Bilateral Thyroid Gland LL-NM2080-D05 Preoperative Localisation of Parathyroid Adenomas: Using Serum Parathyroid Hormone, Calcium, and Phosphate Levels as Predictors LL-NM2081-D06 The Role of MIBG and Octreotide Scans in Staging Neuro-Endocrine Malignancy: Are Both Tests Always Required? LL-NM2082-D07 Is Biliary Dyskinesia in Nuclear Scintigraphic Imaging Indicative of Clinical Pathology? LL-NM2083-D08 Percent Residual Gastric Activity at Four Hours (%RGA@4Hrs) after a Solid Meal Can Not Be Reliably Predicted from Two Hour Data LL-NM2084-D09 SPECT/CT Localization of Extrahepatic Perfusion with a Nuclear Liver Pump Study: Initial Results in 3 Patients with Colorectal Cancer Metastatic to the Liver LL-NM2085-D10 Mechanism of Lung Mosaic Attenuation on X-Ray Computed Tomography in Pulmonary Artery Occlusive Diseases: Comprehensive Assessment with Breath-Hold SPECT-CT Fusion Image LL-NM2086-H01 Co-registered Perfusion SPECT/CT versus Density-Masked CT: Capability for Prediction of Clinical Outcome after Lung Volume Reduction Surgery in Pulmonary Emphysema Patients LL-NM2087-H02 Can Integrated PET/CT Using Fluorodeoxyglucose (FDG) Differentiate the Malignant Tumor from Inflammatory Nodule on Nodular Ground-Glass Opacity? LL-NM2088-H03 Additional Value of Positron Emission Tomography in Staging Esophageal Cancer: A Prospective Cohort Study LL-NM2089-H04 Assessment of Respiratory Lung Motion in Patients with Chronic Obstructive Pulmonary Diseases with Respiratory-gated SPECT Image-derived 3D Displacement Vector Images
  13. 13. LL-NM2090-H08 Comparative Study in the Staging of Locally Advanced Breast Cancer Using 18F- Fluorodeoxyglucose PET/CT and MRI LL-NM2091-H06 Absorbed Dose from Daily Routine Practice in an 18F-FDG Producing Radiopharmacy LL-NM2092-H07 Fractal Texture Analysis of Lung Scan for Diagnosis of Pulmonary Embolism LL-NM2093-H05 Actual Effects of Intravascular Clots on Peripheral Lung Perfusion/CT Attenuation in Pulmonary Thromboembolism: Assessment with Breath-hold SPECT-CT Fusion Images LL-NM2094-H09 False Positive F-18 FDG PET Scan in Patients with Pulmonary Involvement in the Hypereosinophilic Syndrome Simulating Lung Cancer LL-NM2095-H10 FDG Avidity in the Head and Neck on PET/CT: Normal Ranges during Aging LL-NM2096-L01 F-18 FDG PET/CT in the Management of Melanoma LL-NM2097-L02 Effect of Collimation on Measurement of 131-I Total Body Clearance LL-NM2098-L03 Assessment of Regional Ventilation in Pulmonary Bullous Lesions Associated with Pulmonary Emphysema: Evaluation with Dynamic Pulmonary Xenon-133 Gas SPECT LL-NM2099-L04 Evaluation of Pleural Uptake with FDG- PET/CT LL-NM2100-L05 Reproducibility of SUV in FDG-PET with the Two Different PET Scanners LL-NM2101-L06 The Accuracy of FDG-PET cN2 in Patients with Lung Cancer: Radiological/Pathological Correlation LL-NM2102-L07 Detection of Distant Neck or Thoracic Metastatic Lesions in Recurrent Abdominopelvic Malignancies with FDG PET-CT LL-NM2103-L08 Evaluation of Detectability and Diagnostic Capability for Neck Lymphnode Metastasis from Head and Neck Cancer Using C-11 Methionine PET/CT LL-NM2104-L09 Dual Time PET Imaging Is Useful in Detection of Recurrent and Metastatic Ovarian Cancer by PET/CT
  14. 14. LL-NM2105-L10 Value of FDG-PET and Image Fusion for Optimization of Target Volume Definition in CT-guided Interstitial High Dose Rate Single Fraction Brachytherapy of Colorectal Liver Metastases LL-NM2106-R01 Assessment of Cross-sectional Lung Ventilation-Perfusion Inequality in Smokers with Ventilation/Perfusion Quotient Images Derived from Tc-99m-Technegas/MAA SPECT LL-NM2107-R02 Retention Index in Double Phase 18FDG-PET Correlates with the Histological Grading of Brain Tumors LL-NM2108-R03 Diagnostic Value of Kinetic Analysis Using FDG Dynamic PET in Patients with Malignant Primary Brain Tumor LL-NM2109-R04 Dopamine Neuron Loss Assessment on Brazillian Early and Late Onset Parkinsons Disease Patients by [99mTc]-TRODAT-1 SPECT LL-NM2110-R05 Measurement of Gastric Contraction Wave Propagation with Fourier Analysis of Dynamic Gastric Scintigraphy LL-NM2111-R06 The 18 F-FAZA/FDG Uptake Ratio: Potential Index of Tumor Hypoxia? LL-NM2112-R07 F-18 FDG PET/CT Evaluation of Sarcoma Patients LL-NM2113-R08 The Efficacy of Computer Detection of Kidney in PET/CT Images and Kidney SUV Statistics in PET Images LL-NM2114-R09 PET/CT in Lymphoma: Prospective Study of Full-dose Enhanced PET/CT versus Low-dose Unenhanced PET/CT LL-NM2115-R10 I-123 IMP SPECT of Primary Lesions and Metastases of Cutaneous of Malignant Melanoma: Comparison with F-18 FDG PET LL-PD4012-H04 Can Pediatric PET-CT Attenuation Correction Images Be Used for Diagnosis? An Experimental Study LL-PD4013-H05 Eosinophilic Colitis in Pediatric Patients: Assessment with Scintigraphy with 99mTc White Blood Cells
  15. 15. Informatics Special Event Space No. Exhibit Title LL-IN1214-IC IHE Nuclear Medicine: What’s New in 2006?